453 related articles for article (PubMed ID: 22396004)
1. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
[TBL] [Abstract][Full Text] [Related]
2. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
[TBL] [Abstract][Full Text] [Related]
3. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
[TBL] [Abstract][Full Text] [Related]
4. Perceptions of contralateral breast cancer: an overestimation of risk.
Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
[TBL] [Abstract][Full Text] [Related]
5. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution.
Jones NB; Wilson J; Kotur L; Stephens J; Farrar WB; Agnese DM
Ann Surg Oncol; 2009 Oct; 16(10):2691-6. PubMed ID: 19506956
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
[TBL] [Abstract][Full Text] [Related]
7. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients.
McGuire KP; Santillan AA; Kaur P; Meade T; Parbhoo J; Mathias M; Shamehdi C; Davis M; Ramos D; Cox CE
Ann Surg Oncol; 2009 Oct; 16(10):2682-90. PubMed ID: 19653046
[TBL] [Abstract][Full Text] [Related]
8. Mastectomy and contralateral prophylactic mastectomy rates: an institutional review.
Damle S; Teal CB; Lenert JJ; Marshall EC; Pan Q; McSwain AP
Ann Surg Oncol; 2011 May; 18(5):1356-63. PubMed ID: 21125335
[TBL] [Abstract][Full Text] [Related]
9. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
10. The influence of preoperative MRI on breast cancer treatment.
Miller BT; Abbott AM; Tuttle TM
Ann Surg Oncol; 2012 Feb; 19(2):536-40. PubMed ID: 21751044
[TBL] [Abstract][Full Text] [Related]
11. Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database.
Barry PN; Johnson RR; Harkenrider MM; Freeman AB; Kruse B; Wilson MR; Pan J; Dragun AE
Am J Med Sci; 2012 Dec; 344(6):452-6. PubMed ID: 22395715
[TBL] [Abstract][Full Text] [Related]
12. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.
Yao K; Stewart AK; Winchester DJ; Winchester DP
Ann Surg Oncol; 2010 Oct; 17(10):2554-62. PubMed ID: 20461470
[TBL] [Abstract][Full Text] [Related]
13. Incremental risk associated with contralateral prophylactic mastectomy and the effect on adjuvant therapy.
Eck DL; Perdikis G; Rawal B; Bagaria S; McLaughlin SA
Ann Surg Oncol; 2014 Oct; 21(10):3297-303. PubMed ID: 25047470
[TBL] [Abstract][Full Text] [Related]
14. Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies.
Mattos D; Gfrerer L; Ling IT; Reish RG; Hughes KS; Halpern EF; Cetrulo C; Colwell AS; Winograd JM; Yaremchuk MJ; Austen WG; Liao EC
Ann Surg Oncol; 2016 Mar; 23(3):767-75. PubMed ID: 26577123
[TBL] [Abstract][Full Text] [Related]
15. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
[TBL] [Abstract][Full Text] [Related]
16. Locoregional recurrence after mastectomy with immediate transverse rectus abdominis myocutaneous (TRAM) flap reconstruction.
Patterson SG; Teller P; Iyengar R; Carlson GW; Gabram-Mendola SG; Losken A; Styblo T; Torres M; Wood WC; Perez SD; Mosunjac M; Rizzo M
Ann Surg Oncol; 2012 Aug; 19(8):2679-84. PubMed ID: 22476750
[TBL] [Abstract][Full Text] [Related]
17. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
Pinell-White XA; Kolegraff K; Carlson GW
Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
[TBL] [Abstract][Full Text] [Related]
18. Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer.
Stucky CC; Gray RJ; Wasif N; Dueck AC; Pockaj BA
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():330-7. PubMed ID: 20853055
[TBL] [Abstract][Full Text] [Related]
19. Predicting nipple-areolar involvement using preoperative breast MRI and primary tumor characteristics.
Steen ST; Chung AP; Han SH; Vinstein AL; Yoon JL; Giuliano AE
Ann Surg Oncol; 2013 Feb; 20(2):633-9. PubMed ID: 22965571
[TBL] [Abstract][Full Text] [Related]
20. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction.
Koslow S; Pharmer LA; Scott AM; Stempel M; Morrow M; Pusic AL; King TA
Ann Surg Oncol; 2013 Oct; 20(11):3422-9. PubMed ID: 23720070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]